Table 1 Renal disease QTL identified in genome-wide linkage analyses of genetic rat models
From: Mapping genetic determinants of kidney damage in rat models
Cross | Ref. | Sex | Treatment | Week | Phenotype | QTL on RNO |
|---|---|---|---|---|---|---|
BUF × WKY BC | m | Normal diet | 20–60 | Proteinuria | 13 | |
FHH × ACI BC | m | Normal diet | 36 | Proteinuria | 1 (Rf-1), 1 (Rf-2) | |
36 | Focal glomerulosclerosis | 1 (Rf-1), 1 (Rf-2) | ||||
FHH × ACI F2 | m | Normal diet, Nx | 14 | Albuminuria | 1 (Rf-1), 1 (Rf-2), 1 (Bpfh1), 3, 14, 17 | |
14 | Proteinuria | 1 (Rf-1), 1 (Rf-2), 1 (Bpfh1), 3, 14, 17 | ||||
14 | Focal glomerulosclerosis | 1 (Rf-1), 1 (Rf-2), 3, 14 | ||||
FHH.1BN × FHH F2 | f | 0.4% NaCl | 20 | Renal blood flow autoregulation | 1 | |
GK × BN F2 | m | 1% NaCl | 12, 24, 36, 48 | Proteinuria | 5, 7 | |
48 | Glomerulosclerosis | 5, 7 | ||||
48 | Tubular sclerosis | 5, 7 | ||||
12, 24, 36, 48 | Diabetes phenotypes | 1, 4, 5, 10 | ||||
LH × LN F2 | m | 0.3% NaCl | 29–31 | Creatinine levels | 1, 2, 17 | |
Kidney weight | 1, 2, 3, 10, 17 | |||||
MWF × Lew BC | m | 0.2% NaCl | 8, 14, 24 | Albuminuria | 1 (QTL1), 6 (QTL1), 12, 17 | |
8, 14, 24 | Proteinuria | 1 (QTL1), 17 | ||||
24 | Superficial glomeruli | X | ||||
24 | Surface glomeruli | 1, 13 | ||||
MWF × SHR BC | m | 0.2% NaCl | 8, 14, 24 | Albuminuria | 1 (QTL2), 4, 6 (QTL2), 7, 8, 9, 15, X | |
8, 14, 24 | Proteinuria | 1 (QTL2), 6, 8, 15 | ||||
24 | Renal interstitial fibrosis | 6 | ||||
24 | Superficial glomeruli | 2, 6, 7, 9 | ||||
24 | Surface glomeruli | 6 | ||||
SBH × SBN F2 | m | 0.2% NaCl, Nx | 12, 20, 24, 28, 32 | Proteinuria | 2, 3, 17, 20 | |
SBH × SBN BC | m | 0.2% NaCl, Nx | 16 | Proteinuria | 2, 6, 9, 20 | |
f | 0.2% NaCl, Nx | 20 | Proteinuria | 11, 13, 20 | ||
SHR-A3 × SHR-B2 F2 | m | 0.2% NaCl | 25 | Immunoglobulin G subclasses associated with albuminuria | 6 | |
SHRSP × SHR F2 | m, f | 1% NaCl | 10 | Renal vascular/parenchymal lesions | 1 (QTL1+2), 4, 10, 16 | |
SS × SHR F2 | m | 0.2% NaCl | 14 | Albuminuria | 2, 6 (QTL2), 8, 9, 10, 11, 19 | |
SS × SHR BC | m | 0.3% NaCl | 8, 12, 16 | Albuminuria | 1, 2, 6 (QTL2), 8, 9, 10, 11, 13, 19 | |
8, 12, 16 | Proteinuria | 1, 2, 6 (QTL1+2), 8, 9, 10, 11, 19 | ||||
16 | Kidney lesion grade | 2, 6, 8, 11, 13, 19 | ||||
SS × SHR F2 | m | 2% NaCl | 8, 12, 16 | Albuminuria | 1, 6 (QTL2), 8, 9, 13 | |
8, 12, 16 | Proteinuria | 1, 6 (QTL2), 8, 9 | ||||
16 | Kidney lesion grade | 1, 2, 8, 9, 13 | ||||
SS × SHR F2 | m | 4% NaCl | 14 | Albuminuria | 6 (QTL1+2), 8, 9, 19 | |
14 | Proteinuria | 3, 6 (QTL1), 19 | ||||
14 | Renal interstitial fibrosis | 20 | ||||
14 | Tubulointerstitial inflammation grading | 3 | ||||
14 | Microangiopathy | 5 | ||||
SS × BN F2 | f | 0.4/0.1/8% NaCl | 12 | Proteinuria | 2, 11 | |
12 | Focal glomerulosclerosis | 2 | ||||
12 | Glomerular injury | 11 |